Litcius/Paper detail

Discovery of 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)-N,N-diethylpiperidine-1-carboxamide as kinase inhibitor for the treatment of colorectal cancer

Yuting Zhou, Xingwei Xu, Fei Wang, Huan He, Baohui Qi

2020Bioorganic Chemistry20 citationsDOI

Topics & Concepts

ChemistryRegorafenibCytotoxicityCarboxamideApoptosisPharmacologyKinaseQuinolineMTT assayContext (archaeology)IC50ToxicityIn vitroStereochemistryBiochemistryInternal medicineMedicineBiologyColorectal cancerCancerOrganic chemistryPaleontologyPI3K/AKT/mTOR signaling in cancerSynthesis and biological activityQuinazolinone synthesis and applications
Discovery of 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)-N,N-diethylpiperidine-1-carboxamide as kinase inhibitor for the treatment of colorectal cancer | Litcius